Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes

por Galicia-Vázquez, Gabriela, Aloyz, Raquel
Publicado 2018

eIF4AII is dispensable for miRNA-mediated gene silencing

por Galicia-Vázquez, Gabriela, Chu, Jennifer, Pelletier, Jerry
Publicado 2015

Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition

por Galicia-Vázquez, Gabriela, Smith, Sarah, Aloyz, Raquel
Publicado 2018

Regulation of Eukaryotic Initiation Factor 4AII by MyoD during Murine Myogenic Cell Differentiation

por Galicia-Vázquez, Gabriela, Di Marco, Sergio, Lian, Xian J., Ma, Jennifer F., Gallouzi, Imed E., Pelletier, Jerry
Publicado 2014

CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A

por Chu, Jennifer, Galicia-Vázquez, Gabriela, Cencic, Regina, Mills, John R., Katigbak, Alexandra, Porco, John A., Pelletier, Jerry
Publicado 2016

Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol

por Cencic, Regina, Carrier, Marilyn, Galicia-Vázquez, Gabriela, Bordeleau, Marie-Eve, Sukarieh, Rami, Bourdeau, Annie, Brem, Brigitte, Teodoro, Jose G., Greger, Harald, Tremblay, Michel L., Porco, John A., Pelletier, Jerry
Publicado 2009

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

por Fooks, Katie, Galicia-Vazquez, Gabriela, Gife, Victor, Schcolnik-Cabrera, Alejandro, Nouhi, Zaynab, Poon, William W. L., Luo, Vincent, Rys, Ryan N., Aloyz, Raquel, Orthwein, Alexandre, Johnson, Nathalie A., Hulea, Laura, Mercier, Francois E.
Publicado 2022